Abstract
Bone and mineral diseases encompass a variety of conditions that involve altered skeletal homeostasis and are frequently associated with changes in circulating calcium, phosphate, or vitamin D metabolites. These disorders often have a genetic etiology and comprise monogenic disorders caused by a single-gene mutation, which may be germline or somatic, or an oligogenic or polygenic condition involving multiple genetic variants. Single-gene mutations causing Mendelian diseases are usually highly penetrant, whereas the gene variants contributing to oligogenic or polygenic disorders are each associated with smaller effects with additional contributions from environmental factors. The detection of monogenic disorders is clinically important and facilitates timely assessment and management of the patient and their affected relatives. The diagnosis of monogenic metabolic bone disorders requires detailed clinical assessment of the wide variety of symptoms and signs associated with these diseases. Thus, clinicians should undertake a systematic approach commencing with careful history taking and physical examination, followed by appropriate laboratory and skeletal imaging investigations. Finally, clinicians should be familiar with the range of molecular genetic tests available to ensure their appropriate use and interpretation. These considerations are reviewed in this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adamska M, MacDonald BT, Sarmast ZH, Oliver ER, Meisler MH (2004) En1 and Wnt7a interact with Dkk1 during limb development in the mouse. Dev Biol 272:134–144. https://doi.org/10.1016/j.ydbio.2004.04.026
Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 76:7–20. https://doi.org/10.1002/0471142905.hg0720s76
Ai M, Heeger S, Bartels CF, Schelling DK, Osteoporosis-Pseudoglioma Collaborative G (2005) Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. Am J Hum Genet 77:741–753. https://doi.org/10.1086/497706
Arvai K et al (2016) Next-generation sequencing of common osteogenesis imperfecta-related genes in clinical practice. Sci Rep 6:28417. https://doi.org/10.1038/srep28417
Asharani PV et al (2012) Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish. Am J Hum Genet 90:661–674. https://doi.org/10.1016/j.ajhg.2012.02.026
Baldridge D et al (2008) CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutat 29:1435–1442. https://doi.org/10.1002/humu.20799
Balemans W et al (2002) Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 39:91–97
Bardai G, Ward LM, Trejo P, Moffatt P, Glorieux FH, Rauch F (2017) Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta. Osteoporos Int 28:2095–2101. https://doi.org/10.1007/s00198-017-4031-2
Baron R, Kneissel M (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med 19:179–192. https://doi.org/10.1038/nm.3074
Becker J et al (2011) Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 88:362–371. https://doi.org/10.1016/j.ajhg.2011.01.015
Bergwitz C et al (2006) SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet 78:179–192. https://doi.org/10.1086/499409
Biesecker LG, Spinner NB (2013) A genomic view of mosaicism and human disease. Nat Rev Genet 14:307–320. https://doi.org/10.1038/nrg3424
Boyce AM, Collins MT (2019) Fibrous dysplasia/McCune-Albright syndrome: a rare, mosaic disease of Gαs activation. Endocr Rev. https://doi.org/10.1210/endrev/bnz011
Breveglieri G, D’Aversa E, Finotti A, Borgatti M (2019) Non-invasive prenatal testing using fetal DNA. Mol Diagn Ther 23:291–299. https://doi.org/10.1007/s40291-019-00385-2
Brunkow ME et al (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577–589
Caparros-Martin JA et al (2017) Molecular spectrum and differential diagnosis in patients referred with sporadic or autosomal recessive osteogenesis imperfecta. Mol Genet Genomic Med 5:28–39. https://doi.org/10.1002/mgg3.257
Carpenter TO, Shaw NJ, Portale AA, Ward LM, Abrams SA, Pettifor JM (2017) Rickets. Nat Rev Dis Primers 3:17101. https://doi.org/10.1038/nrdp.2017.101
Chesi A et al (2019) Genome-scale capture C promoter interactions implicate effector genes at GWAS loci for bone mineral density. Nat Commun 10:1260. https://doi.org/10.1038/s41467-019-09302-x
Cho TJ et al (2012) A single recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet 91:343–348. https://doi.org/10.1016/j.ajhg.2012.06.005
Cohen AS, Wilson SL, Trinh J, Ye XC (2015) Detecting somatic mosaicism: considerations and clinical implications. Clin Genet 87:554–562. https://doi.org/10.1111/cge.12502
Collins M (2018) Burosumab: at long last, an effective treatment for FGF23-associated hypophosphatemia. J Bone Miner Res 33:1381–1382. https://doi.org/10.1002/jbmr.3544
Collins MT, Singer FR, Eugster E (2012) McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis 7(Suppl 1):S4. https://doi.org/10.1186/1750-1172-7-S1-S4
ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348. https://doi.org/10.1038/81664
Cosman F et al (2016) Romosozumab treatment in postmenopausal women with Osteoporosis. N Engl J Med 375:1532–1543. https://doi.org/10.1056/NEJMoa1607948
Cummings SR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765. https://doi.org/10.1056/NEJMoa0809493
Dave BJ, Sanger WG (2007) Role of cytogenetics and molecular cytogenetics in the diagnosis of genetic imbalances. Semin Pediatr Neurol 14:2–6. https://doi.org/10.1016/j.spen.2006.11.003
Devuyst O, Thakker RV (2010) Dent's disease. Orphanet J Rare Dis 5:28. https://doi.org/10.1186/1750-1172-5-28
Dixon PH et al (1998) Mutational analysis of PHEX gene in X-linked hypophosphatemia. J Clin Endocrinol Metab 83:3615–3623. https://doi.org/10.1210/jcem.83.10.5180
Estrada K et al (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44:491–501. https://doi.org/10.1038/ng.2249
Faienza MF, Ventura A, Colucci S, Cavallo L, Grano M, Brunetti G (2016) Bone fragility in turner syndrome: mechanisms and prevention strategies. Front Endocrinol 7:34. https://doi.org/10.3389/fendo.2016.00034
Falardeau F, Camurri MV, Campeau PM (2017) Genomic approaches to diagnose rare bone disorders. Bone 102:5–14. https://doi.org/10.1016/j.bone.2016.07.020
Feng JQ et al (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38:1310–1315. https://doi.org/10.1038/ng1905
Ferlin A, Schipilliti M, Di Mambro A, Vinanzi C, Foresta C (2010) Osteoporosis in Klinefelter’s syndrome. Mol Hum Reprod 16:402–410. https://doi.org/10.1093/molehr/gaq026
Ferrari SL (2018) Osteoporosis: Romosozumab to rebuild the foundations of bone strength. Nat Rev Rheumatol 14:128. https://doi.org/10.1038/nrrheum.2018.5
Fijalkowski I et al (2016) A novel domain-specific mutation in a sclerosteosis patient suggests a role of LRP4 as an anchor for sclerostin in human bone. J Bone Miner Res 31:874–881. https://doi.org/10.1002/jbmr.2782
Gandomi SK, Parra M, Reeves D, Yap V, Gau CL (2015) Array-CGH is an effective first-tier diagnostic test for EFTUD2-associated congenital mandibulofacial dysostosis with microcephaly. Clin Genet 87:80–84. https://doi.org/10.1111/cge.12328
Gijsbers AC, Ruivenkamp CA (2011) Molecular karyotyping: from microscope to SNP arrays. Horm Res Paediatr 76:208–213. https://doi.org/10.1159/000330406
GnomAD (2019) Genome aggregation database. https://gnomad.broadinstitute.org. Accessed 3 Dec 2019
Goldstein DB, Allen A, Keebler J, Margulies EH, Petrou S, Petrovski S, Sunyaev S (2013) Sequencing studies in human genetics: design and interpretation. Nat Rev Genet 14:460–470. https://doi.org/10.1038/nrg3455
Grigelioniene G et al (2019) Gain-of-function mutation of microRNA-140 in human skeletal dysplasia. Nat Med 25:583–590. https://doi.org/10.1038/s41591-019-0353-2
Hannan FM et al (2012) Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. Hum Mol Genet 21:2768–2778. https://doi.org/10.1093/hmg/dds105
Hannan FM, Kallay E, Chang W, Brandi ML, Thakker RV (2018) The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat Rev Endocrinol 15:33–51. https://doi.org/10.1038/s41574-018-0115-0
Hannan FM, Newey PJ, Whyte MP, Thakker RV (2019) Genetic approaches to metabolic bone diseases. Br J Clin Pharmacol 85:1147–1160. https://doi.org/10.1111/bcp.13803
Imel EA et al (2019) Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 393:2416–2427. https://doi.org/10.1016/S0140-6736(19)30654-3
Johnston JJ, Biesecker LG (2013) Databases of genomic variation and phenotypes: existing resources and future needs. Hum Mol Genet 22:R27–R31. https://doi.org/10.1093/hmg/ddt384
Kang H et al (2018) Somatic activating mutations in MAP 2K1 cause melorheostosis. Nat Commun 9:1390. https://doi.org/10.1038/s41467-018-03720-z
Karasik D, Rivadeneira F, Johnson ML (2016) The genetics of bone mass and susceptibility to bone diseases. Nat Rev Rheumatol 12:323–334. https://doi.org/10.1038/nrrheum.2016.48
Kemp JP et al (2017) Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis. Nat Genet 49:1468–1475. https://doi.org/10.1038/ng.3949
Kharbanda M, Tolmie J, Joss S (2015) How to use... microarray comparative genomic hybridisation to investigate developmental disorders. Arch Dis Child Educ Pract Ed 100:24–29. https://doi.org/10.1136/archdischild-2014-306022
Kiper POS et al (2016) Cortical-bone fragility--insights from sFRP4 deficiency in Pyle’s disease. N Engl J Med 374:2553–2562. https://doi.org/10.1056/NEJMoa1509342
Koczkowska M et al (2017) Genomic findings in patients with clinical suspicion of 22q11.2 deletion syndrome. J Appl Genet 58:93–98. https://doi.org/10.1007/s13353-016-0366-1
Krishnan V, Bryant HU, Macdougald OA (2006) Regulation of bone mass by Wnt signaling. J Clin Investig 116:1202–1209. https://doi.org/10.1172/JCI28551
Kruglyak L (2008) The road to genome-wide association studies. Nat Rev Genet 9:314–318. https://doi.org/10.1038/nrg2316
Laine CM et al (2013) WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta. N Engl J Med 368:1809–1816. https://doi.org/10.1056/NEJMoa1215458
Lazarus S, Zankl A, Duncan EL (2014) Next-generation sequencing: a frameshift in skeletal dysplasia gene discovery. Osteoporos Int 25:407–422. https://doi.org/10.1007/s00198-013-2443-1
Lee SH et al (2016) Prediction of future osteoporotic fracture occurrence by genetic profiling: a 6-year follow-up observational study. J Clin Endocrinol Metab 101:1215–1224. https://doi.org/10.1210/jc.2015-3972
Lek M et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285–291. https://doi.org/10.1038/nature19057
Lemos MC, Thakker RV (2015) GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders. Hum Mutat 36:11–19. https://doi.org/10.1002/humu.22696
Levy-Litan V et al (2010) Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet 86:273–278. https://doi.org/10.1016/j.ajhg.2010.01.010
Lindhurst MJ et al (2011) A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 365:611–619. https://doi.org/10.1056/NEJMoa1104017
Little RD et al (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11–19. https://doi.org/10.1086/338450
Lorenz-Depiereux B et al (2006) Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 78:193–201. https://doi.org/10.1086/499410
Manrai AK et al (2016) Genetic misdiagnoses and the potential for health disparities. N Engl J Med 375:655–665. https://doi.org/10.1056/NEJMsa1507092
Mao B et al (2002) Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417:664–667. https://doi.org/10.1038/nature756
Marini JC et al (2017) Osteogenesis imperfecta. Nat Rev Dis Primers 3:17052. https://doi.org/10.1038/nrdp.2017.52
Mitchell JA et al (2016) Rare EN1 variants and pediatric bone mass. J Bone Miner Res 31:1513–1517. https://doi.org/10.1002/jbmr.2833
Morello R et al (2006) CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127:291–304. https://doi.org/10.1016/j.cell.2006.08.039
Morris JA et al (2019) An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet 51:258–266. https://doi.org/10.1038/s41588-018-0302-x
Mortier GR et al (2019) Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A 179:2393–2419. https://doi.org/10.1002/ajmg.a.61366
Moverare-Skrtic S et al (2014) Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat Med 20:1279–1288. https://doi.org/10.1038/nm.3654
Nesbit MA et al (2013a) Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia. N Engl J Med 368:2476–2486. https://doi.org/10.1056/NEJMoa1300253
Nesbit MA et al (2013b) Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat Genet 45:93–97. https://doi.org/10.1038/ng.2492
Newey PJ, Gorvin CM, Whyte MP, Thakker RV (2018) Chapter 1 – introduction to genetics of skeletal and mineral metabolic diseases. In: Thakker RV, Whyte MP, Eisman JA, Igarashi T (eds) Genetics of bone biology and skeletal disease, 2nd edn. Academic Press, Cambridge, pp 1–21. https://doi.org/10.1016/B978-0-12-804182-6.00001-0
Pearce SH et al (1996) A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335:1115–1122
Pekkinen M et al (2019) Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2. JCI Insight 4:e126180. https://doi.org/10.1172/jci.insight.126180
Pignolo RJ, Shore EM, Kaplan FS (2011) Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis 6:80. https://doi.org/10.1186/1750-1172-6-80
Polla DL et al (2015) Use of targeted exome sequencing for molecular diagnosis of skeletal disorders. PLoS One 10:e0138314. https://doi.org/10.1371/journal.pone.0138314
Pyott SM, Pepin MG, Schwarze U, Yang K, Smith G, Byers PH (2011) Recurrence of perinatal lethal osteogenesis imperfecta in sibships: parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance. Genet Med 13:125–130. https://doi.org/10.1097/GIM.0b013e318202e0f6
Pyott SM et al (2013) WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta. Am J Hum Genet 92:590–597. https://doi.org/10.1016/j.ajhg.2013.02.009
Ralston SH (2008) Juvenile Paget’s disease, familial expansile osteolysis and other genetic osteolytic disorders. Best Pract Res Clin Rheumatol 22:101–111. https://doi.org/10.1016/j.berh.2007.11.005
Rehm HL (2013) Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 14:295–300. https://doi.org/10.1038/nrg3463
Richards JB, Zheng HF, Spector TD (2012) Genetics of osteoporosis from genome-wide association studies: advances and challenges. Nat Rev Genet 13:576–588. https://doi.org/10.1038/nrg3228
Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30
Rigter T, van Aart CJ, Elting MW, Waisfisz Q, Cornel MC, Henneman L (2014) Informed consent for exome sequencing in diagnostics: exploring first experiences and views of professionals and patients. Clin Genet 85:417–422. https://doi.org/10.1111/cge.12299
Rivadeneira F, Makitie O (2016) Osteoporosis and bone mass disorders: from gene pathways to treatments. Trends Endocrinol Metab 27:262–281. https://doi.org/10.1016/j.tem.2016.03.006
Roizen JD et al (2018) CYP3A4 mutation causes vitamin D-dependent rickets type 3. J Clin Investig 128:1913–1918. https://doi.org/10.1172/JCI98680
Schwarz JM, Rodelsperger C, Schuelke M, Seelow D (2010) MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7:575–576. https://doi.org/10.1038/nmeth0810-575
Semler O et al (2012) A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am J Hum Genet 91:349–357. https://doi.org/10.1016/j.ajhg.2012.06.011
Shendure J, Balasubramanian S, Church GM, Gilbert W, Rogers J, Schloss JA, Waterston RH (2017) DNA sequencing at 40: past, present and future. Nature 550:345–353. https://doi.org/10.1038/nature24286
Stechman MJ, Loh NY, Thakker RV (2009) Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol 24:2321–2332. https://doi.org/10.1007/s00467-008-0807-0
Styrkarsdottir U et al (2013) Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature 497:517–520. https://doi.org/10.1038/nature12124
Tafaj O, Juppner H (2017) Pseudohypoparathyroidism: one gene, several syndromes. J Endocrinol Invest 40:347–356. https://doi.org/10.1007/s40618-016-0588-4
Tengan CH, Kiyomoto BH, Rocha MS, Tavares VL, Gabbai AA, Moraes CT (1998) Mitochondrial encephalomyopathy and hypoparathyroidism associated with a duplication and a deletion of mitochondrial deoxyribonucleic acid. J Clin Endocrinol Metab 83:125–129. https://doi.org/10.1210/jcem.83.1.4497
Tenorio J et al (2017) Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia. Am J Med Genet A 173:601–610. https://doi.org/10.1002/ajmg.a.37991
Thakker RV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990–3011. https://doi.org/10.1210/jc.2012-1230
Toledo RA et al (2017) Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas. Nat Rev Endocrinol 13:233–247. https://doi.org/10.1038/nrendo.2016.185
van den Veyver IB, Eng CM (2015) Genome-wide sequencing for prenatal detection of Fetal single-gene disorders. Cold Spring Harb Perspect Med 5:a023077. https://doi.org/10.1101/cshperspect.a023077
van Dijk FS et al (2013) PLS3 mutations in X-linked osteoporosis with fractures. N Engl J Med 369:1529–1536. https://doi.org/10.1056/NEJMoa1308223
van Lierop AH, Hamdy NA, van Egmond ME, Bakker E, Dikkers FG, Papapoulos SE (2013) Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers. J Bone Miner Res 28:848–854. https://doi.org/10.1002/jbmr.1794
Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC (2016) SIFT missense predictions for genomes. Nat Protoc 11:1–9. https://doi.org/10.1038/nprot.2015.123
Vermeesch JR, Voet T, Devriendt K (2016) Prenatal and pre-implantation genetic diagnosis. Nat Rev Genet 17:643–656. https://doi.org/10.1038/nrg.2016.97
Ward LD, Kellis M (2012) Interpreting noncoding genetic variation in complex traits and human disease. Nat Biotechnol 30:1095–1106. https://doi.org/10.1038/nbt.2422
Watanabe S et al (2002) Association between activating mutations of calcium-sensing receptor and Bartter’s syndrome. Lancet 360:692–694
Whyte MP (2016) Hypophosphatasia – aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12:233–246. https://doi.org/10.1038/nrendo.2016.14
Whyte MP (2018a) Chapter 26 – Mendelian disorders of RANKL/OPG/RANK/NF-κB signaling. In: Thakker RV, Whyte MP, Eisman JA, Igarashi T (eds) Genetics of bone biology and skeletal disease, 2nd edn. Academic Press, Cambridge, pp 453–468. https://doi.org/10.1016/B978-0-12-804182-6.00026-5
Whyte MP (2018b) Chapter 28 – hypophosphatasia and how alkaline phosphatase promotes mineralization. In: Thakker RV, Whyte MP, Eisman JA, Igarashi T (eds) Genetics of bone biology and skeletal disease, 2nd edn. Academic Press, Cambridge, pp 481–505. https://doi.org/10.1016/B978-0-12-804182-6.00028-9
Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S (2002) Osteoprotegerin deficiency and juvenile Paget’s disease. N Engl J Med 347:175–184. https://doi.org/10.1056/NEJMoa013096
Whyte MP et al (2018) Sclerosteosis: report of type 1 or 2 in three Indian Tamil families and literature review. Bone 116:321–332. https://doi.org/10.1016/j.bone.2018.07.022
Whyte MP et al (2019) New explanation for autosomal dominant high bone mass: mutation of low-density lipoprotein receptor-related protein 6. Bone 127:228–243. https://doi.org/10.1016/j.bone.2019.05.003
Wilichowski E et al (1997) Hypoparathyroidism and deafness associated with pleioplasmic large scale rearrangements of the mitochondrial DNA: a clinical and molecular genetic study of four children with Kearns-Sayre syndrome. Pediatr Res 41:193–200. https://doi.org/10.1203/00006450-199704001-01165
Yang G et al (2018) SIRT1/HERC4 locus associated with bisphosphonate-induced osteonecrosis of the jaw: an exome-wide association analysis. J Bone Miner Res 33:91–98. https://doi.org/10.1002/jbmr.3285
Zhang J et al (2019) Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA. Nat Med 25:439–447. https://doi.org/10.1038/s41591-018-0334-x
Zheng HF et al (2012) WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet 8:e1002745. https://doi.org/10.1371/journal.pgen.1002745
Zheng HF et al (2015) Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture. Nature 526:112–117. https://doi.org/10.1038/nature14878
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hannan, F.M., Newey, P.J., Whyte, M.P., Thakker, R.V. (2020). Genetics of Skeletal Disorders. In: Stern, P.H. (eds) Bone Regulators and Osteoporosis Therapy. Handbook of Experimental Pharmacology, vol 262. Springer, Cham. https://doi.org/10.1007/164_2020_350
Download citation
DOI: https://doi.org/10.1007/164_2020_350
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57377-5
Online ISBN: 978-3-030-57378-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)